Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alice Lee
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
116 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- San Jorge Children'S Hospital
San Juan, Puerto Rico
- University Pediatric Hospital
San Juan, Puerto Rico
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Banner Children'S at Desert
Mesa, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke'S Medical Center
Denver, Colorado, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Uf Health Cancer Institute - Gainesville
Gainesville, Florida, United States
- Memorial Regional Hospital/joe Dimaggio Children'S Hospital
Hollywood, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Nicklaus Children'S Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine-Sylvester Cancer Center
Miami, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Arnold Palmer Hospital for Children
Orlando, Florida, United States
- Nemours Children'S Hospital
Orlando, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Saint Joseph'S Hospital/children'S Hospital-Tampa
Tampa, Florida, United States
- Saint Mary'S Medical Center
West Palm Beach, Florida, United States
- Children'S Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, United States
- Saint Luke'S Cancer Institute - Boise
Boise, Idaho, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Osf Children'S Hospital of Illinois
Peoria, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Ascension Saint Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jun 2018
- Primary completion
- 30 Sept 2023
- Completion
- 30 Dec 2026
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 20
- Registry id
- NCT03210714
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.